383 related articles for article (PubMed ID: 10819570)
41. Tetracycline-inducible transgene expression mediated by a single AAV vector.
Chtarto A; Bender HU; Hanemann CO; Kemp T; Lehtonen E; Levivier M; Brotchi J; Velu T; Tenenbaum L
Gene Ther; 2003 Jan; 10(1):84-94. PubMed ID: 12525840
[TBL] [Abstract][Full Text] [Related]
42. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
43. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.
Schiedner G; Morral N; Parks RJ; Wu Y; Koopmans SC; Langston C; Graham FL; Beaudet AL; Kochanek S
Nat Genet; 1998 Feb; 18(2):180-3. PubMed ID: 9462752
[TBL] [Abstract][Full Text] [Related]
44. pUNISHER: a high-level expression cassette for use with recombinant viral vectors for rapid and long term in vivo neuronal expression in the CNS.
Montesinos MS; Chen Z; Young SM
J Neurophysiol; 2011 Dec; 106(6):3230-44. PubMed ID: 21957229
[TBL] [Abstract][Full Text] [Related]
45. Beta-adrenoceptor blockade markedly attenuates transgene expression from cytomegalovirus promoters within the cardiovascular system.
Salem HK; Ranjzad P; Driessen A; Appleby CE; Heagerty AM; Kingston PA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2267-74. PubMed ID: 16888240
[TBL] [Abstract][Full Text] [Related]
46. Long-term transgene expression in the RPE after gene transfer with a high-capacity adenoviral vector.
Kreppel F; Luther TT; Semkova I; Schraermeyer U; Kochanek S
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1965-70. PubMed ID: 12037006
[TBL] [Abstract][Full Text] [Related]
47. Heart muscle-specific gene expression using replication defective recombinant adenovirus.
Rothmann T; Katus HA; Hartong R; Perricaudet M; Franz WM
Gene Ther; 1996 Oct; 3(10):919-26. PubMed ID: 8908506
[TBL] [Abstract][Full Text] [Related]
48. Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy.
Amalfitano A; Chamberlain JS
Gene Ther; 1997 Mar; 4(3):258-63. PubMed ID: 9135740
[TBL] [Abstract][Full Text] [Related]
49. Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.
Suzuki T; Sasaki T; Yano K; Sakurai F; Kawabata K; Kondoh M; Hayakawa T; Yagi K; Mizuguchi H
Virus Res; 2011 Jun; 158(1-2):154-60. PubMed ID: 21470569
[TBL] [Abstract][Full Text] [Related]
50. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector.
Wang Q; Greenburg G; Bunch D; Farson D; Finer MH
Gene Ther; 1997 May; 4(5):393-400. PubMed ID: 9274715
[TBL] [Abstract][Full Text] [Related]
51. Engineering tissue-specific expression of a recombinant adenovirus: selective transgene transcription in the pancreas using the amylase promoter.
Dematteo RP; McClane SJ; Fisher K; Yeh H; Chu G; Burke C; Raper SE
J Surg Res; 1997 Oct; 72(2):155-61. PubMed ID: 9356237
[TBL] [Abstract][Full Text] [Related]
52. Insertion of CTCF-binding sites into a first-generation adenovirus vector reduces the innate inflammatory response and prolongs transgene expression.
Schaack J; Qiao L; Walkiewicz MP; Stonehouse M; Engel DA; Vazquez-Torres A; Nordeen SK; Shao J; Moorhead JW
Virology; 2011 Mar; 412(1):136-45. PubMed ID: 21272906
[TBL] [Abstract][Full Text] [Related]
53. Efficient gene transfer and long-term expression in neurons using a recombinant adenovirus with a neuron-specific promoter.
Navarro V; Millecamps S; Geoffroy MC; Robert JJ; Valin A; Mallet J; Gal La Salle GL
Gene Ther; 1999 Nov; 6(11):1884-92. PubMed ID: 10602384
[TBL] [Abstract][Full Text] [Related]
54. Neuron-restrictive silencer elements mediate neuron specificity of adenoviral gene expression.
Millecamps S; Kiefer H; Navarro V; Geoffroy MC; Robert JJ; Finiels F; Mallet J; Barkats M
Nat Biotechnol; 1999 Sep; 17(9):865-9. PubMed ID: 10471926
[TBL] [Abstract][Full Text] [Related]
55. Heart-specific targeting of beta-galactosidase by the ventricle-specific cardiac myosin light chain 2 promoter using adenovirus vectors.
Griscelli F; Gilardi-Hebenstreit P; Hanania N; Franz WM; Opolon P; Perricaudet M; Ragot T
Hum Gene Ther; 1998 Sep; 9(13):1919-28. PubMed ID: 9741430
[TBL] [Abstract][Full Text] [Related]
56. Improvement of lentiviral transfer vectors using cis-acting regulatory elements for increased gene expression.
Real G; Monteiro F; Burger C; Alves PM
Appl Microbiol Biotechnol; 2011 Sep; 91(6):1581-91. PubMed ID: 21674167
[TBL] [Abstract][Full Text] [Related]
57. ICAM-1 induction in respiratory cells exposed to a replication-deficient recombinant adenovirus in vitro and in vivo.
Nicolis E; Tamanini A; Melotti P; Rolfini R; Berton G; Cassatella MA; Bout A; Pavirani A; Cabrini G
Gene Ther; 1998 Jan; 5(1):131-6. PubMed ID: 9536274
[TBL] [Abstract][Full Text] [Related]
58. Gene therapy expression vectors based on the clotting Factor IX promoter.
Hoag H; Gore J; Barry D; Mueller C
Gene Ther; 1999 Sep; 6(9):1584-9. PubMed ID: 10490768
[TBL] [Abstract][Full Text] [Related]
59. Myosin regulatory elements as vectors for gene transfer by intramuscular injection.
Skarli M; Kiri A; Vrbova G; Lee CA; Goldspink G
Gene Ther; 1998 Apr; 5(4):514-20. PubMed ID: 9614576
[TBL] [Abstract][Full Text] [Related]
60. Stem cell gene therapy, position effects and chromatin insulators.
Neff T; Shotkoski F; Stamatoyannopoulos G
Stem Cells; 1997; 15 Suppl 1():265-71. PubMed ID: 9368350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
